Abstract:Purpose: The primary aim of this study was to investigate, using an experimental rat model of osteoarthritis(OA), the effect of a selective p38 mitogen activated protein kinase inhibitor,SB203580, on the development of structural changes.Additional aims were to assess the effects of the inhibitor on levels of matrixmetalloproteinase 3 (MMP-3) and MMP-13(collagenase 3) in OA cartilage and to explore the relation between the MMP-3,13 expression and the severity of OA. Methods: OA was induced in 40 SD rats by anterior cruciate ligament transection (ACLT).After surgical, rats with OA were randomly divided into A_D groups: Rats of group A received 0.1 ml intra-articular injection of SB203580 at high concentration of 100um/L. Each treatment started immediately after surgery, once a week;those in group B were treated under the same condition using SB203580 with low concentration of 10um/L and those in group C received 0.1ml of intra-articular 0.9% Sodium Chloride injection,animals of group D were not injected as controls after ACLT. The animals were killed 8 weeks after surgery. Macroscopicand histologic studies were performed on the cartilage. The levels of MMP-3,13 in OA cartilage chondrocytes were evaluated by immunohistochemistry and western-blotting. Results: All ACLT knees demonstrated osteoarthritic changes. Cartilage degradation in the control group was significantly more severe than that in the experimental group both on the macroscopic grading scale and on Mankin’s grading scale(P <0.05). Immunohistochemical study showed that in the experimental group MMP-3,13 was predominantly expressed in the superficial and upper intermediate layers of cartilage, and the amount of MMP-3,13 in the experimental group was also lower than that in control group(P <0.05). In western-blotting the amount of MMP3,13 was reduced by the treatment of the inhibitor. The protein levels of MMP-3 and MMP-13 in cartilage of inhibitor injection groups were significantly lower than those of Sodium Chloride group and untreated group. There was no significant difference in MMP-3 and MMP-13 expression between the different concentration inhibitor injection groups. No significant difference in MMP-3 and MMP-13 expression in cartilage was found between Sodium Chloride group and control group. Conclusions: This study demonstrates that, in vivo,SB203580, a selective inhibitor of p38MAPK, can partially decrease the development of some of the structural changes in the early phases of experimental OA and significantly reduces the severity of cartilage degradation. This effect was associated with a reduction in the level of MMP-3,13 in OA cartilage, which probably explains the action of the drug and thus may be a potential drug for the treatment of OA.

Effect of SB203580 on NF-κB expression induced by nitric oxide in rabbit articular chondrocytes

Apoptosis induced by NO via phosphorylation of p38 MAPK that stimulates NF-κB, p53 and caspase-3 activation in rabbit articular chondrocytes

The P38 MAPK Signal Transduction Pathway is Involved in Rabbit Articular Chondrocyte Apoptosis Induced by NO

[Role of JNK Signaling Pathway in Chondrocyte Apoptosis Induced by Nitric Oxide].

Effect of P38 Mitogen Activated Protein Kinase Inhibitor on Chondrocyte Apoptosis in Rats with Osteoarthritis

Chondroprotective Effect of P38 Mitogen Activated Protein Kinase Inhibitor on Experimental Rats Osteoarthritis

Reactivation of NR4A1 Restrains Chondrocyte Inflammation and Ameliorates Osteoarthritis in Rats

The pro-inflammatory effect of NR4A3 in osteoarthritis

SNP-induced apoptosis may be mediated with caspase inhibitor by JNK signaling pathways in rabbit articular chondrocytes.

[Effects of Intra-Articular Injection of P38 Mitogen-Activated Protein Kinase Inhibitor on Matrix Metalloproteinase in Articular Cartilage of a Rat Model of Osteoarthritis].

Inhibitory Effects of SRT1720 on the Apoptosis of Rabbit Chondrocytes by Activating SIRT1 Via P53/bax and NF-κB/PGC-1α Pathways

The study of nuclear factor kappa B decoy oligodeoxyribonucleotide on NO production of chondrocytes induced by IL-1β

P173 THE EFFECTS OF INTRA-ARTICULAR INJECTION OF P38 MAPK INHIBITOR ON MATRIX METALLOPROTEINASE IN CARTILAGE OF EXPERIMENTAL OSTEOARTHRITIS MODEL

Morin Inhibits Interleukin-1Β-induced Nitric Oxide and Prostaglandin E2 Production in Human Chondrocytes

The Effects of PDTC on Interleukin-1Β-induced Nitric Oxide Production in Chondrocytes

Paeoniflorin Inhibits IL-1β-induced MMP Secretion Via the NF-κB Pathway in Chondrocytes.

Dapansutrile ameliorated chondrocyte inflammation and osteoarthritis through suppression of MAPK signaling pathway

SP600125 Blocks the Proteolysis of Cytoskeletal Proteins in Apoptosis Induced by Gas Signaling Molecule (NO) Via Decreasing the Activation of Caspase-3 in Rabbit Chondrocytes.

Increase in NO Causes Osteoarthritis and Chondrocyte Apoptosis and Chondrocyte ERK Plays a Protective Role in the Process

Rosmarinic Acid Down‐regulates NO and PGE 2 Expression Via MAPK Pathway in Rat Chondrocytes

Wnt/β-catenin and Hedgehog Pathways Are Involved in the Inflammatory Effect of Interleukin 18 on Rat Chondrocytes